Sees Q4 adjusted EBITDA $21M-$23M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HROW:
- Harrow Health options imply 17.9% move in share price post-earnings
- Harrow launches Vevye Access for All
- HROW Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Harrow executes five-year supply, development agreement for Triesence
- Reddit initiated, Cigna downgraded: Wall Street’s top analyst calls
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue